Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Brek Eaton

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 1, 2024
Analogs of α-conotoxin PnIC selectively inhibit α7β2- over α7-only subtype nicotinic acetylcholine receptors via a novel allosteric mechanismAndrew A George, Sabin J John, Linda M Lucero, et al.
Journal of Medicinal Chemistry|September 13, 2011
Discovery of isoxazole analogues of sazetidine-A as selective α4β2-nicotinic acetylcholine receptor partial agonists for the treatment of depressionJianhua Liu, Li-Fang Yu, J Brek Eaton, et al.
Pharmacology Research & Perspectives|December 16, 2014
The potent and selective α4β2*/α6*-nicotinic acetylcholine receptor partial agonist 2-[5-[5-((S)Azetidin-2-ylmethoxy)-3-pyridinyl]-3-isoxazolyl]ethanol demonstrates antidepressive-like behavior in animal models and a favorable ADME-tox profileLi-Fang Yu, J Brek Eaton, Han-Kun Zhang, et al.
Journal of Medicinal Chemistry|December 17, 2011
Chemistry and behavioral studies identify chiral cyclopropanes as selective α4β2-nicotinic acetylcholine receptor partial agonists exhibiting an antidepressant profileHankun Zhang, Werner Tückmantel, J Brek Eaton, et al.
Journal of Medicinal Chemistry|August 30, 2012
Insights into the structural determinants required for high-affinity binding of chiral cyclopropane-containing ligands to α4β2-nicotinic acetylcholine receptors: an integrated approach to behaviorally active nicotinic ligandsHan-Kun Zhang, J Brek Eaton, Li-Fang Yu, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 1, 2024
Analogs of α-conotoxin PnIC selectively inhibit α7β2- over α7-only subtype nicotinic acetylcholine receptors via a novel allosteric mechanismAndrew A George, Sabin J John, Linda M Lucero, et al.
Journal of Medicinal Chemistry|September 13, 2011
Discovery of isoxazole analogues of sazetidine-A as selective α4β2-nicotinic acetylcholine receptor partial agonists for the treatment of depressionJianhua Liu, Li-Fang Yu, J Brek Eaton, et al.
Pharmacology Research & Perspectives|December 16, 2014
The potent and selective α4β2*/α6*-nicotinic acetylcholine receptor partial agonist 2-[5-[5-((S)Azetidin-2-ylmethoxy)-3-pyridinyl]-3-isoxazolyl]ethanol demonstrates antidepressive-like behavior in animal models and a favorable ADME-tox profileLi-Fang Yu, J Brek Eaton, Han-Kun Zhang, et al.
Journal of Medicinal Chemistry|December 17, 2011
Chemistry and behavioral studies identify chiral cyclopropanes as selective α4β2-nicotinic acetylcholine receptor partial agonists exhibiting an antidepressant profileHankun Zhang, Werner Tückmantel, J Brek Eaton, et al.
Journal of Medicinal Chemistry|August 30, 2012
Insights into the structural determinants required for high-affinity binding of chiral cyclopropane-containing ligands to α4β2-nicotinic acetylcholine receptors: an integrated approach to behaviorally active nicotinic ligandsHan-Kun Zhang, J Brek Eaton, Li-Fang Yu, et al.
Pageof 3